vTv Therapeutics (VTVT) Other Operating Expenses (2014 - 2016)

vTv Therapeutics has disclosed Other Operating Expenses across 3 years of filings, most recently posting $529000.0 for Q3 2016.

• Other Operating Expenses for Q3 2016 came in at $529000.0, down 9.57% year-over-year; the trailing twelve-month figure through Jun 2017 was $529000.0 (down 68.25% YoY), and the FY2016 annual result was $795000.0, down 66.13% from the prior year.
• Other Operating Expenses came in at $529000.0 for Q3 2016 at vTv Therapeutics, up from $72000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $815000.0 in Q4 2015 to a low of $72000.0 in Q2 2016.
• The 3-year median for Other Operating Expenses is $448000.0 (2014), against an average of $423100.0.
• Across the five-year window, Other Operating Expenses surged 178.16% in 2015 and sank 87.05% in 2016, its largest moves.
• vTv Therapeutics' Other Operating Expenses stood at $293000.0 in 2014, then soared by 178.16% to $815000.0 in 2015, then plunged by 35.09% to $529000.0 in 2016.
• The last three Other Operating Expenses figures came in at $529000.0 (Q3 2016), $72000.0 (Q2 2016), and $194000.0 (Q1 2016), per Business Quant data.